Immunosuppressive treatment of experimental pyelonephritis with a combination of oxytetracycline and azathioprine.
D000372:Agglutination Tests; D000818:Animals; D001379:Azathioprine / Q000008:administration & dosage / Q000627:therapeutic use*; D004926:Escherichia coli / Q000276:immunology; D004927:Escherichia coli Infections / Q000276:immunology / Q000473:pathology; D005455:Fluorescent Antibody Technique; D006386:Hemagglutination Tests; D007165:Immunosuppression Therapy; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D010118:Oxytetracycline / Q000008:administration & dosage / Q000627:therapeutic use*; D011704:Pyelonephritis / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology / Q000473:pathology; D011817:Rabbits / Q000276:immunology; D051381:Rats; D014556:Urine / Q000166:cytology
D001379:Azathioprine; D010118:Oxytetracycline